A comparison of the abuse liability and dependence potential of nicotine patch, gum, spray and inhaler / Robert West (2000)  

Public Titre : A comparison of the abuse liability and dependence potential of nicotine patch, gum, spray and inhaler Type de document : document électronique Auteurs : Robert West, Auteur ; Peter Hajek, Auteur ; J. Foulds, Auteur ; Fredrik Nilsson, Auteur ; Sylvia May, Auteur ; Anna Meadows, Auteur Editeur : Springer Année de publication : 2000 Collection : Psychopharmacology num. 149(3) Importance : p.198-202 Langues : Anglais (eng) Catégories : [TABAC] étude:recherche:recherche clinique:essai clinique randomisé [TABAC] sevrage tabagique:méthode de sevrage:méthode individuelle:approche pharmacologique:chewing-gum [TABAC] sevrage tabagique:méthode de sevrage:méthode individuelle:approche pharmacologique:inhalateur [TABAC] sevrage tabagique:méthode de sevrage:méthode individuelle:approche pharmacologique:patch à la nicotine [TABAC] sevrage tabagique:méthode de sevrage:méthode individuelle:approche pharmacologique:spray nasal [TABAC] tabagisme:dépendance tabagique:dépendance psychologique [TABAC] tabagisme:évaluation du tabagisme:test de dépendance à la nicotine Index. décimale : TA 6.2.3.1 Substitution nicotinique Résumé : Rationale: Nicotine replacement therapy (NRT) in varying forms is becoming widely used. Clinicians, therapists and regulatory authorities are interested in the abuse liability and dependence potential of the different forms. Objectives: To compare the abuse liability and dependence potential of nicotine gum, transdermal patch, spray and inhaler. Methods: 504 male and female smokers seeking help with stopping smoking were randomly allocated to the four products. Measures were taken at the designated quit date, then 1 week, 4 weeks, 12 weeks and 15 weeks later. Smokers were advised to use the product for up to 12 weeks. Those still using the product at the 12-week visit were advised to cease use by week 14. Measures included: pleasantness and satisfaction ratings at weeks 1 and 4 (used as a marker of abuse liability); ratings of feeling dependent on NRT at weeks 1, 4, 12 and 15 (used as a marker of subjective dependence); mood and physical symptoms ratings at weeks 12 and 15 (the change being used to assess physical dependence on NRT), continued usage of NRT at week 15 (used as an marker of behavioural dependence). Results: Average ratings of pleasantness were low. The nicotine patch was rated as less unpleasant to use than all other products. There were no significant differences between the products in terms of satisfaction or subjective dependence except at week 15 when no patch users rated themselves as dependent. Continued use of NRT at week 15 was related to rate of delivery of nicotine from the products - 2% for patch, 7% for gum and inhaler, 10% for spray (P<0.05 for linear association). Among those En ligne : https://doi.org/10.1007/s002130000382 Format de la ressource électronique : Article en ligne Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=10350

Aucun avis, veuillez vous identifier pour ajouter le vôtre !

Effect of a short bout of exercise on tobacco withdrawal symptoms and desire to smoke / Michael Ussher (2001)

Public Titre : Effect of a short bout of exercise on tobacco withdrawal symptoms and desire to smoke Type de document : texte imprimé Auteurs : Michael Ussher, Auteur ; Paola Nunziata, Auteur ; Mark Cropley, Auteur ; Robert West, Auteur Editeur : Springer Année de publication : 2001 Collection : Psychopharmacology num. 158 Importance : p.66-72 Langues : Anglais (eng) Catégories : [TABAC] sevrage tabagique [TABAC] tabagisme:risque:facteur associé:sport Index. décimale : TA 6.7 Facteurs influents (grossesse, adolescence…) Résumé : Les effets d'une courte période d'exercice sur les symptômes de sevrage et du désir de fumer. Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=2992

Exemplaires (1)

Code-barres	Cote	Support	Localisation	Section	Disponibilité
TA 002121	TA 6.7 USS E	Article/Périodique	Bibliothèque FARES	Tabac	Consultation sur place Exclu du prêt

Aucun avis, veuillez vous identifier pour ajouter le vôtre !

Light and intermittent cigarette smokers / Chris R. E. Coggins (2009)  

Public Titre : Light and intermittent cigarette smokers : a review Type de document : document électronique Auteurs : Chris R. E. Coggins, Auteur ; Lenn E. Murelle, Auteur ; Richard A. Carchman, Auteur Editeur : Springer Année de publication : 2009 Collection : Psychopharmacology num. 207 Importance : p. 343-363 Présentation : tab. Langues : Anglais (eng) Catégories : [DIVERS] géographie:Amérique:Amérique du Nord:Etats-Unis [TABAC] tabagisme:dépendance tabagique [TABAC] tabagisme:habitude tabagique Index. décimale : TA 4.1 Habitudes tabagiques Résumé : Rationale: Growing proportions of smokers in the USA do not smoke everyday and can be referred to as light and intermittent smokers (LITS). Despite a current prevalence of LITS in the USA estimated at 25-33% of all smokers, a systematic review of the literature on this group of smokers has yet to be written. Objectives: The aim of this paper is to review and evaluate research on LITS and to identify, describe and discuss commonalities and differences between LITS and daily smokers. Methods: The primary databases used to search for publications were Pub Med (National Library of Medicine) and SCOPUS (Elsevier). Results: LITS inhale smoke and have post-smoking blood nicotine concentrations that are broadly equivalent to those found in daily smokers. However, LITS differ from daily smokers with regard to cigarette consumption and frequency of cigarette use, sociodemographic and socioeconomic characteristics, motives, personality traits, dependence, withdrawal and craving, response to smoking-related cues, quitting perception, past-smoking status, and initiation. Conclusions: In contrast to daily smokers, LITS show few or no signs of dependence as currently defined by DSM-IV criteria, appear to exercise more self-control, seem to be less impulsive, and their smoking experience is primarily associated with positive rather than negative reinforcement. Conclusions drawn from the reviewed literature highlight the multivariate factors that must be taken into account when defining LITS and emphasize the importance of further research on this increasing fraction of smokers. The potential implications of increased LITS prevalence on smoking-related disease risks remain to be thoroughly investigated. En ligne : https://doi.org/10.1007/s00213-009-1675-4 Format de la ressource électronique : Article en ligne Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=9773

Aucun avis, veuillez vous identifier pour ajouter le vôtre !

Varenicline as a smoking cessation aid in schizophrenia / Sunny J. Dutra (2012)  

Public Titre : Varenicline as a smoking cessation aid in schizophrenia : effects on smoking behavior and reward sensitivity Type de document : texte imprimé Auteurs : Sunny J. Dutra, Auteur ; Luke E. Stoeckel, Auteur ; Sara V. Carlini, Auteur ; Diego A. Pizzagalli, Auteur Editeur : Springer Année de publication : 2012 Collection : Psychopharmacology num. 219 Importance : p.25-34 Langues : Anglais (eng) Catégories : [TABAC] sevrage tabagique:méthode de sevrage:méthode individuelle:approche pharmacologique:varénicline [TABAC] tabagisme:pathologie:pathologie neurologique:schizophrénie Index. décimale : TA 6.2.3.2 Autres produits Résumé : RATIONALE: Smoking rates are up to five times higher in people with schizophrenia than in the general population, placing these individuals at high risk for smoking-related health problems. Varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, is a promising aid for smoking cessation in this population. To maximize treatment efficacy while minimizing risks, it is critical to identify reliable predictors of positive response to varenicline in smokers with schizophrenia. OBJECTIVES: Negative symptoms of schizophrenia are related to dysfunctions in the brain reward system, are associated with nicotine dependence, and may be improved by nicotine or nicotinic receptor agonists, suggesting that smoking cessation may be especially difficult for patients with substantial negative symptoms. The purpose of the study was to evaluate negative symptoms as predictors of response to varenicline. METHODS: Patients with schizophrenia (N = 53) completed a 12-week smoking cessation trial combining varenicline with cognitive behavioral therapy. Negative symptoms were assessed via the Scale for the Assessment of Negative Symptoms (Andreasen 1983). Outcomes included smoking abstinence as assessed by self-report and expired carbon monoxide. Change in performance on a probabilistic reward task was used as an index of change in reward sensitivity during treatment. RESULTS: At week 12, 32 participants met criteria for 14-day point-prevalence abstinence. Patients with lower baseline symptoms of affective flattening (more typical affect) were more likely to achieve smoking abstinence and demonstrated larger increases in reward sensitivity during treatment. CONCLUSIONS: These data suggest that affective flattening symptoms in smokers with schizophrenia may predict response to varenicline. En ligne : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3267781/ Format de la ressource électronique : HTML Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=8094

Aucun avis, veuillez vous identifier pour ajouter le vôtre !